NCT00414765View on ClinicalTrials.gov

Aldesleukin in Participants With Metastatic Renal Cell Carcinoma or Metastatic Melanoma

PHASE4CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

September 3, 2008

Primary Completion Date

March 28, 2010

Study Completion Date

March 28, 2010

Conditions
Metastatic Renal Cell CarcinomaMetastatic Melanoma
Interventions
DRUG

Aldesleukin

Trial Locations (4)

40202

James Graham Brown Cancer Center, Louisville

80045

University of Colorado Cancer Center, Aurora

90033

USC/Kenneth Norris Comprehensive Cancer Center, Los Angeles

03756

Dartmouth Hitchcock Medical Center, Lebanon

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY